Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01132885 · ClinicalTrials.gov registry record
Defining the Brain Phenotype of Children With Williams Syndrome
A clinical trial of Williams Syndrome and Duplication, sponsored by National Institute of Mental Health (NIMH).
- Recruiting
- Registry status
- 415
- Enrollment target
- 1
- Study location
NCT01132885: Recruiting study of Williams Syndrome and Duplication, sponsored by National Institute of Mental Health (NIMH).
NCT01132885 is a study of Williams Syndrome and Duplication that is actively recruiting participants, run by National Institute of Mental Health (NIMH). The registered enrollment target is 415 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01132885, a study of Williams Syndrome and Duplication, is actively recruiting participants, sponsored by National Institute of Mental Health (NIMH).
- RECRUITING
- Registry status
- 415 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: \- Little is known about how the brain changes during childhood and adolescence, how genes affect this process, or how the brains of people with 7q11.23 genetic variation change during this period. Researchers are interested in using magnetic resonance imaging to study how the brain changes in healthy children and children with 7q11.23 genetic variation, including Williams syndrome and 7q11.23 duplication syndrome. Objectives: \- To study developmental changes in the brains of healthy children and children who have been diagnosed with Williams syndrome,7q11.23 duplication syndrome, or other 7q11.23 genetic variation. Eligibility: * Healthy children and adolescents between 5 and 17 years of age. * Children and adolescents between 5 and 17 years of age who have been diagnosed with Williams syndrome, 7q11.23 duplication syndrome, or have other 7q11.23 genetic variation. Design: * Participants will have a brief physical examination and tests of memory, attention, concentration, and thinking. Parents will be asked about their child s personality, behavior characteristics, and social interaction and communication skills. * Both participants and their parents may be asked to complete additional questionnaires or take various tests as required for the study. * Participants will have approximately 10 hours of magnetic resonance imaging (MRI) scanning, usually over 4 to 5 days, within a one month period. Some of these tests will require the participants to do specific tasks while inside the MRI scanner. * Participants will be asked to return to the National Institutes of Health clinical center to repeat these procedures every 2 years thereafter until age 18.
Primary Outcome
fMRI Task Procedures
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 415 participants |
| Start Date | 2011-01-23 |
What NCT01132885 shows while recruiting
NCT01132885 is an observational study that tracks outcomes without assigning an intervention. The registered 415 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Williams Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT01132885 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT01132885 about?
NCT01132885 is a clinical study titled "Defining the Brain Phenotype of Children With Williams Syndrome". Background: \- Little is known about how the brain changes during childhood and adolescence, how genes affect this process, or how the brains of people with 7q11.23 genetic variation change during this period. Researchers are interested in using magnetic resonance imaging to study how the brain cha...
What is the current status of trial NCT01132885?
This trial is currently recruiting. The enrollment target is 415 participants. The study started on 2011-01-23.
What conditions does trial NCT01132885 study?
This clinical trial studies the following conditions: Williams Syndrome, Duplication.
Who is sponsoring clinical trial NCT01132885?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01132885 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Williams Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05142605 · 415 participants · NA
Evaluation of Grief Therapy Approaches for Bereaved Parents
- NCT03527537 · 416 participants · Phase 4
Gestational Diabetes and Pharmacotherapy (GAP)
- NCT05007782 · 416 participants · Phase 1
Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors
- NCT05520099 · 416 participants
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI